Steve Cohen’s Latest Stock Picks: Biotech and Immunology Companies with Strong Potential
As debt-ceiling negotiations and economic data point to potential challenges ahead, investors seek guidance to navigate the volatile market. Wall Street investing legend Steve Cohen, Chairman and CEO of Point72, has amassed a fortune through a high-risk/high-reward strategy. Monitoring Cohen’s latest stock purchases can provide valuable insights, and two of his recent positions have also…